These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8016121)

  • 1. Two cellular proteins that bind to wild-type but not mutant p53.
    Iwabuchi K; Bartel PL; Li B; Marraccino R; Fields S
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6098-102. PubMed ID: 8016121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
    Gorina S; Pavletich NP
    Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2.
    Iwabuchi K; Li B; Massa HF; Trask BJ; Date T; Fields S
    J Biol Chem; 1998 Oct; 273(40):26061-8. PubMed ID: 9748285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
    Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
    BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M.
    Naumovski L; Cleary ML
    Mol Cell Biol; 1996 Jul; 16(7):3884-92. PubMed ID: 8668206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.
    Nakagawa H; Koyama K; Murata Y; Morito M; Akiyama T; Nakamura Y
    Cancer Res; 2000 Jan; 60(1):101-5. PubMed ID: 10646860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
    Thukral SK; Blain GC; Chang KK; Fields S
    Mol Cell Biol; 1994 Dec; 14(12):8315-21. PubMed ID: 7969167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
    Datta B; Li B; Choubey D; Nallur G; Lengyel P
    J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
    Derbyshire DJ; Basu BP; Serpell LC; Joo WS; Date T; Iwabuchi K; Doherty AJ
    EMBO J; 2002 Jul; 21(14):3863-72. PubMed ID: 12110597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.
    Lopez CD; Ao Y; Rohde LH; Perez TD; O'Connor DJ; Lu X; Ford JM; Naumovski L
    Mol Cell Biol; 2000 Nov; 20(21):8018-25. PubMed ID: 11027272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2.
    Yang JP; Hori M; Takahashi N; Kawabe T; Kato H; Okamoto T
    Oncogene; 1999 Sep; 18(37):5177-86. PubMed ID: 10498867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).
    Tidow H; Veprintsev DB; Freund SM; Fersht AR
    J Biol Chem; 2006 Oct; 281(43):32526-33. PubMed ID: 16887812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.
    Matsuzawa S; Takayama S; Froesch BA; Zapata JM; Reed JC
    EMBO J; 1998 May; 17(10):2736-47. PubMed ID: 9582267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P; Milner J
    Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a protein-binding domain of p53.
    Ruppert JM; Stillman B
    Mol Cell Biol; 1993 Jun; 13(6):3811-20. PubMed ID: 8388547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Foord OS; Bhattacharya P; Reich Z; Rotter V
    Nucleic Acids Res; 1991 Oct; 19(19):5191-8. PubMed ID: 1923804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of cellular proliferation using p53 DNA recognition site-related oligonucleotides.
    Ré RN; Cook JL
    Am J Med Sci; 1996 Feb; 311(2):65-72. PubMed ID: 8615376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic approach to mapping the p53 binding site in the MDM2 protein.
    Freedman DA; Epstein CB; Roth JC; Levine AJ
    Mol Med; 1997 Apr; 3(4):248-59. PubMed ID: 9131587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.